85 related articles for article (PubMed ID: 671851)
1. [Dipyridamole therapy in the nephrotic syndrome (author's transl)].
Tojo S; Narita M; Suzuki H; Sano M; Koyama A; Tsuchiya T; Yamamoto S; Tsuchida H; Shishido H; Watanabe K
Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):255-66. PubMed ID: 671851
[No Abstract] [Full Text] [Related]
2. [Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test (author's transl)].
Ueda Y; Tojo S; Hatano M; Furukawa T; Yoshinaga K; Kinoshita Y; Takeuchi J; Kato E; Ohno J; Kobayashi K; Abe H; Omae S
Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1171-83. PubMed ID: 396401
[No Abstract] [Full Text] [Related]
3. [The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method (author's transl)].
Ishikawa H; Honjo A; Hayashi M; Hamaguchi T; Morita T; Tesutani T; Yamamoto M; Fujimoto Y; Okubo A; Oka G
Nihon Jinzo Gakkai Shi; 1979 Feb; 21(2):135-55. PubMed ID: 381736
[No Abstract] [Full Text] [Related]
4. Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
Ishikawa H; Honjo A; Hayashi M; Hamaguchi T; Morita T; Shindo T; Tetsutani T; Yamamoto T; Okubo H; Oka G
Arzneimittelforschung; 1982; 32(3):301-9. PubMed ID: 7200790
[No Abstract] [Full Text] [Related]
5. Dipyridamole therapy in the nephrotic syndrome.
Tojo S; Narita M; Koyama A; Sano M; Suzuki H; Tsuchiya T; Tsuchida H; Yamamoto S; Shishido H
Contrib Nephrol; 1978; 9():111-27. PubMed ID: 352614
[TBL] [Abstract][Full Text] [Related]
6. Platelet aggregation and dipyridamole therapy in nephrotics.
Chen WY; Chen TJ; Yen TS; Hsieh BS; Tsai TJ; Hsu HC
Taiwan Yi Xue Hui Za Zhi; 1982 Jan; 81(1):31-42. PubMed ID: 6954237
[No Abstract] [Full Text] [Related]
7. [Cell-mediated immunity and effects of cyclophosphamide on primary nephrotic syndrome (author's transl)].
Okura T; Matsuo S; Kumon S; Hibi I; Tamaki S; Watanabe Y; Kinoshita Y
Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1395-403. PubMed ID: 7334719
[No Abstract] [Full Text] [Related]
8. [Avascular (aseptic) bone necrosis in SLE and nephrotic syndrome following corticosteroid therapy (author's transl)].
Inage H; Koyama A; Narita M; Tojo S; Iesato K; Takei I; Wakasin Y; Wakasin M
Nihon Jinzo Gakkai Shi; 1980 Apr; 22(4):393-9. PubMed ID: 7401392
[No Abstract] [Full Text] [Related]
9. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
Murphy BF; McDonald I; Fairley KF; Kincaid-Smith PS
Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
[TBL] [Abstract][Full Text] [Related]
10. A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis.
Futrakul P
Int J Pediatr Nephrol; 1980 Mar; 1(1):18-21. PubMed ID: 7343523
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)].
Shibata M; Shimizu K; Kishi T; Kobayashi K; Sakai H; Sugiyama H; Oguri M
Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1197-207. PubMed ID: 6450847
[No Abstract] [Full Text] [Related]
12. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
[No Abstract] [Full Text] [Related]
13. [Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis].
Kacprzyk F; Chrzanowski W; Kubala L; Orłowski Z
Pol Merkur Lekarski; 1997 Feb; 2(8):96-8. PubMed ID: 9538648
[TBL] [Abstract][Full Text] [Related]
14. [Study on the efficacy of azapropazone--a new nonsteroidal antiinflammatory drug in various forms of renal diseases (author's transl)].
Kaburagi T; Yokoyama S; Mitsunami K; Hanyu I; Takayama S
Nihon Jinzo Gakkai Shi; 1977 Jun; 19(6):421-40. PubMed ID: 926434
[No Abstract] [Full Text] [Related]
15. [Anticoagulant therapy in combination with pulse therapy--about 12 nephritic patients with nephrotic syndrome-- (author's transl)].
Kosaka T; Nagase M; Suzuki Y; Kobayashi N
Nihon Jinzo Gakkai Shi; 1980 Aug; 22(8):1095-111. PubMed ID: 7218582
[No Abstract] [Full Text] [Related]
16. [Renal vein thrombosis: a complication of the nephrotic syndrome? (author's transl)].
Kampf D; Becker H; Höfer W; Baethke R
Med Klin; 1977 Sep; 72(36):1435-42. PubMed ID: 904540
[TBL] [Abstract][Full Text] [Related]
17. Effect of dipyridamole on proteinuria of nephrotic syndrome.
Okada S; Kurata N; Ota Z; Ofuji T
Lancet; 1981 Mar; 1(8222):719-20. PubMed ID: 6110931
[No Abstract] [Full Text] [Related]
18. [Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. I. General protocol. From the DAMAD Study Group (author's transl)].
Diabete Metab; 1982 Jun; 8(2):91-6. PubMed ID: 7049782
[TBL] [Abstract][Full Text] [Related]
19. [The successful therapy of an exacerbation of mesangioproliferative nephritis during pregnancy].
Nikiforova OV; Kozlovskaia NL; Rogov VA; Zozulia OV; Miroshnichenko NG
Ter Arkh; 1995; 67(10):69-70. PubMed ID: 8779113
[No Abstract] [Full Text] [Related]
20. [The effect of albumin and furosemide administration in children with primary nephrotic syndrome (author's transl)].
Rego Filho Ede A; Casoni W
Rev Bras Pesqui Med Biol; 1977; 10(5):299-304. PubMed ID: 594431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
